Sinovac Biotech Company Profile (NASDAQ:SVA)

About Sinovac Biotech (SVA)

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: SVA
  • CUSIP: N/A
Key Metrics:
  • Previous Close: $5.75
  • 50 Day Moving Average: $5.76
  • 200 Day Moving Average: $5.90
  • 52-Week Range: $5.25 - $6.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 114.40
  • P/E Growth: 0.00
  • Market Cap: $325.29M
  • Outstanding Shares: 56,968,000
  • Beta: 0.29
Profitability:
  • Net Margins: -7.09%
  • Return on Equity: -6.81%
  • Return on Assets: -4.54%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 1.91%
  • Quick Ratio: 1.61%

Analyst Ratings

Consensus Ratings for Sinovac Biotech (NASDAQ:SVA) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Sinovac Biotech (NASDAQ:SVA)
Earnings by Quarter for Sinovac Biotech (NASDAQ:SVA)
Earnings History by Quarter for Sinovac Biotech (NASDAQ:SVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/3/2017        
11/28/2016Q316$0.05$0.06$16.76 million$28.74 millionViewN/AView Earnings Details
8/23/2016Q2($0.15)$18.49 billion$1.38 billionViewListenView Earnings Details
5/26/2016Q116($0.01)ViewN/AView Earnings Details
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details
11/11/2015Q315($0.02)($0.03)$27.10 millionViewListenView Earnings Details
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details
5/15/2015Q115$0.02($0.04)$12.70 millionViewN/AView Earnings Details
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.04ViewListenView Earnings Details
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)
Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $0.05 EPS

Dividends

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sinovac Biotech (NASDAQ:SVA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sinovac Biotech (NASDAQ:SVA)
Latest Headlines for Sinovac Biotech (NASDAQ:SVA)
Source:
DateHeadline
prnewswire.com logoSinovac Amends Shareholder Rights Plan - PR Newswire (press release)
www.prnewswire.com - March 25 at 6:12 AM
finance.yahoo.com logoSinovac Amends Shareholder Rights Plan
finance.yahoo.com - March 24 at 8:00 PM
finance.yahoo.com logoWhat We Learned From The Last Avian Flu Outbreak - Yahoo Finance
finance.yahoo.com - January 28 at 8:14 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - January 12 at 2:01 AM
prnewswire.com logoSINOVAC NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100000 ... - PR Newswire (press release)
www.prnewswire.com - January 9 at 1:06 AM
finance.yahoo.com logoSINOVAC NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sinovac Biotech Ltd. To Contact The Firm
finance.yahoo.com - January 9 at 1:06 AM
finance.yahoo.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors
finance.yahoo.com - January 7 at 5:35 AM
finance.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sinovac Biotech Ltd. (SVA)
finance.yahoo.com - January 5 at 6:53 AM
streetinsider.com logoSinovac Biotech (SVA) Responds to Geoinvesting Report, to Commence Internal Investigation - StreetInsider.com
www.streetinsider.com - December 24 at 1:10 AM
streetinsider.com logoSinovac Biotech (SVA) Responds to Geoinvesting Report, to Commence Internal Investigation
www.streetinsider.com - December 23 at 8:08 PM
finance.yahoo.com logo6:03 am Sinovac Biotech responds to a recent report regarding the 'allegations' raised in a research report by Geoinvesting; Audit Committee authorizes the commencement of an internal investigation into 'allegations' made in the report
finance.yahoo.com - December 23 at 8:08 PM
finance.yahoo.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of Sinovac Biotech Ltd. Investors
finance.yahoo.com - December 23 at 8:08 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Sinovac Biotech Ltd. and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - December 23 at 8:08 PM
seekingalpha.com logoSinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy - Seeking Alpha
seekingalpha.com - December 23 at 1:06 AM
prnewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sinovac Biotech Ltd. (SVA) - PR Newswire (press release)
www.prnewswire.com - December 23 at 1:06 AM
streetinsider.com logoHeng Ren Partners Calls for SEC Probe of Sinovac Biotech (SVA) Amid Bribery Case
www.streetinsider.com - December 22 at 3:24 AM
seekingalpha.com logoSinovac Biotech: Court Documents Show CEO Bribed Chinese FDA, Buyout Offers Could Be In Jeopardy
seekingalpha.com - December 22 at 3:24 AM
finance.yahoo.com logoINVESTOR LOSS ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sinovac Biotech Ltd. - SVA
finance.yahoo.com - December 22 at 3:24 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sinovac Biotech Ltd. (SVA)
finance.yahoo.com - December 22 at 3:24 AM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Sinovac Biotech Ltd. and Advises Investors with Losses to Contact the Firm
finance.yahoo.com - December 22 at 3:24 AM
us.rd.yahoo.com logoSinovac Reports Unaudited Third Quarter 2016 Financial Results
us.rd.yahoo.com - November 29 at 3:38 PM
benzinga.com logoEarnings Scheduled For November 28, 2016 - Benzinga
www.benzinga.com - November 29 at 9:59 AM
baystreet.ca logoSinovac Biotech (SVA) Picks up Strength with Earnings in Wings
www.baystreet.ca - November 28 at 1:40 PM
rttnews.com logoEARNINGS SUMMARY: Details of Sinovac Biotech Ltd. Q3 Earnings Report
www.rttnews.com - November 28 at 1:40 PM
biz.yahoo.com logoQ3 2016 Sinovac Biotech Ltd Earnings Release - Before Market Open
biz.yahoo.com - November 28 at 1:40 PM

Social

Frequently Asked Questions for Sinovac Biotech (NASDAQ:SVA)

What is Sinovac Biotech's stock symbol?

Sinovac Biotech trades on the NASDAQ under the ticker symbol "SVA."

How were Sinovac Biotech's earnings last quarter?

Sinovac Biotech Ltd. (NASDAQ:SVA) posted its quarterly earnings results on Tuesday, August, 23rd. The company reported ($0.15) earnings per share (EPS) for the quarter. The business earned $1.38 billion during the quarter, compared to the consensus estimate of $18.49 billion. Sinovac Biotech had a negative net margin of 7.09% and a negative return on equity of 6.81%. During the same period last year, the firm earned $0.02 EPS.

When will Sinovac Biotech make its next earnings announcement?

Sinovac Biotech is scheduled to release their next quarterly earnings announcement on Monday, April, 3rd 2017.

Who owns Sinovac Biotech stock?

Sinovac Biotech's stock is owned by many different of retail and institutional investors. Top institutional shareholders include SAIF Advisors Ltd (18.92%), Orbimed Advisors LLC (4.68%), Renaissance Technologies LLC (2.68%), Two Sigma Investments LP (0.20%), State Street Corp (0.07%) and GLG Partners LP (0.04%).

Who sold Sinovac Biotech stock? Who is selling Sinovac Biotech stock?

Sinovac Biotech's stock was sold by a variety of institutional investors in the last quarter, including GLG Partners LP and Guggenheim Capital LLC.

Who bought Sinovac Biotech stock? Who is buying Sinovac Biotech stock?

Sinovac Biotech's stock was purchased by a variety of institutional investors in the last quarter, including SAIF Advisors Ltd, Renaissance Technologies LLC, Two Sigma Investments LP and State Street Corp.

How do I buy Sinovac Biotech stock?

Shares of Sinovac Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Sinovac Biotech stock cost?

One share of Sinovac Biotech stock can currently be purchased for approximately $5.72.

Sinovac Biotech (SVA) Chart for Wednesday, March, 29, 2017

This page was last updated on 3/29/2017 by MarketBeat.com Staff